These versatile tools enable in-depth studies of cellular responses to 1D, 2D or 3D confinement [85, 148, 152, 159, 160], moderate or tight confinement [157, 158, 153,154,155, 160], short- or long-term confinement [153,154,155, 160], and confining pores or channels [148, 159, 153,154,155]
Roche is pleased to invite investors and analysts to participate in its virtual event on Monday, 8 June 2026, that will highlight the new data from the Phase II CT388-103 study of enicepatide, as well as from the Phase II ZUPREME-1 study of petrelintide
Ayer, A., Fazakerley, D
It means you and your clinician should look at the whole stack, because small effects can add up
The type of GLP-1RA affects the ability to cross the BBB [64]